Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
19 March 2021Website:
http://instilbio.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 28 Jun 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
TIL Latest News
Instil Bio (TIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The heavy selling pressure might have exhausted for Instil Bio, Inc. (TIL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
What type of business is Instil Bio?
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.
What sector is Instil Bio in?
Instil Bio is in the Healthcare sector
What industry is Instil Bio in?
Instil Bio is in the Biotechnology industry
What country is Instil Bio from?
Instil Bio is headquartered in United States
When did Instil Bio go public?
Instil Bio initial public offering (IPO) was on 19 March 2021
What is Instil Bio website?
https://instilbio.com
Is Instil Bio in the S&P 500?
No, Instil Bio is not included in the S&P 500 index
Is Instil Bio in the NASDAQ 100?
No, Instil Bio is not included in the NASDAQ 100 index
Is Instil Bio in the Dow Jones?
No, Instil Bio is not included in the Dow Jones index
When does Instil Bio report earnings?
The next expected earnings date for Instil Bio is 14 August 2024